Description
Crizalk 200mg Capsule 60’S crizalk 200mg capsules are a vital treatment option for patients diagnosed with chronic myeloid leukemia (cml) and philadelphia chromosome-positive acute lymphoblastic leukemia (ph+ all). This potent medication, containing the active ingredient Imatinib, works by inhibiting the BCR-ABL tyrosine kinase, a protein that plays a crucial role in the growth and survival of leukemia cells. By targeting this protein, Crizalk helps to control the progression of these blood cancers, improving overall patient outcomes. These easy-to-swallow capsules are available in a convenient pack of 60, ensuring a 1-month supply for most patients.
Reviews
There are no reviews yet.